Cloxypendyl

This classification denotes an antipsychotic agent with the molecular formula C20H25ClN4OS, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8BK5DLR67A, chemically known as 4-(3-(3-chloro-10h-pyrido(3,2-b)(1,4)benzothiazin-10-yl)propyl)-1-piperazine ethanol but generally known as cloxypendyl, which bears US NIH Compound Identifier 65615. European Medicines Agency schedules Cloxypendyl in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06786MIG. The term CLOXYPENDYL is an International Non-Proprietary Name. CLOXYPENDYL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule cloxypendyl under HS 29349990 and SITC 51579. As of Q4 2014, CLOXYPENDYL remains the US FDA Preferred Term for this commodity. Cloxypendyl bears US NLM identifiers UMLS ID C2699390 and NCI Concept Code C78102. SMILES: CLC1CC2SC3C(N(CCCN4CCN(CC4)CCO)C2NC1)CCCC3.